At the news
? NEUTRALIMPACT 2/10 PRESS-RELEASE filed Mar 25, 2026 at 16:05 ET
Regeneron Pharmaceuticals announced it will release its first quarter 2026 financial results on April 29, 2026, followed by a conference call. The press release contains no financial data, guidance, or material operational updates, it is purely a scheduling notice.
- Regeneron will report Q1 2026 earnings on April 29, 2026, before market open.
- Conference call scheduled for 8:30 AM ET on the same day.
- No financial results, guidance, or operational updates were disclosed in this release.
- This is a routine earnings announcement notice, not a results release.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access